Literature DB >> 23139614

Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.

Jing-Yan Gao1, Bao-Rong Song, Jun-Jie Peng, Yuan-Ming Lu.   

Abstract

AIM: To evaluate the effect of mitochondrial tumor necrosis factor receptor-associated protein-1 (TRAP-1) on the lymph node metastasis (LNM) in Chinese colorectal cancer (CRC) patients, and develop potential LNM-associated biomarkers for CRC using quantitative real-time polymerase chain reaction (RT-PCR) analysis.
METHODS: Differences in mitochondrial TRAP-1 gene expression between primary CRC with LNM (LNM CRC) and without LNM (non-LNM CRC) were assessed in 96 Chinese colorectal carcinoma samples using quantitative RT-PCR analysis, Western blotting, and confirmed with immunohistochemical assay. The relationship between clinicopathological parameters and potential diagnostic biomarkers was also examined.
RESULTS: TRAP-1 was significantly upregulated in LNM CRC compared with non-LNM CRC, which was confirmed by RT-PCR, Western blotting and immunohistochemical assay. The expression of TRAP-1 in two different metastatic potential human colorectal cancer cell lines, LoVo and HT29, was analyzed with Western blotting. The expression level of TRAP-1 was dramatically higher in LoVo than in HT29. Overexpression of TRAP-1 was significantly associated with LNM (90.2% in LNM group vs 22% in non-LNM group, P < 0.001), the advanced tumor node metastasis stage (89.1% in LNM group vs 26.9% in non-LNM group, P < 0.001), the increased 5-year recurrence rate (82.7% in LNM group vs 22.6% in non-LNM group, P < 0.001) and the decreased 5-year overall survival rate (48.4% in LNM vs 83.2% in non-LNM group, P < 0.001). Univariate and multivariate analyses indicated that TRAP-1 expression was an independent prognostic factor for recurrence and survival of CRC patients (Hazard ratio of 2.445 in recurrence, P = 0.017; 2.867 in survival, P = 0.028).
CONCLUSION: Mitochondria TRAP-1 affects the lymph node metastasis in CRC, and may be a potential biomarker for LNM and a prognostic factor in CRC. Over-expression of TRAP-1 is a predictive factor for the poor outcome of colorectal cancer patients.

Entities:  

Keywords:  Colorectal cancer; Hsp90 family; Lymph node metastasis; Mitochondria tumor necrosis factor receptor-associated protein-1; Prognosis; Quantitative real-time polymerase chain reaction analysis

Mesh:

Substances:

Year:  2012        PMID: 23139614      PMCID: PMC3491605          DOI: 10.3748/wjg.v18.i41.5965

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties.

Authors:  S J Felts; B A Owen; P Nguyen; J Trepel; D B Donner; D O Toft
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

Review 2.  The pathophysiology of mitochondrial cell death.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

Review 3.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

Review 4.  TRAP-1, the mitochondrial Hsp90.

Authors:  Dario C Altieri; Gary S Stein; Jane B Lian; Lucia R Languino
Journal:  Biochim Biophys Acta       Date:  2011-08-22

5.  Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function?

Authors:  Lihua He; John J Lemasters
Journal:  FEBS Lett       Date:  2002-02-13       Impact factor: 4.124

6.  A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.

Authors:  Adeela Kamal; Lia Thao; John Sensintaffar; Lin Zhang; Marcus F Boehm; Lawrence C Fritz; Francis J Burrows
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

Review 7.  Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis.

Authors:  I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

8.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Authors:  Jessica B O'Connell; Melinda A Maggard; Clifford Y Ko
Journal:  J Natl Cancer Inst       Date:  2004-10-06       Impact factor: 13.506

Review 9.  Heat shock protein 90.

Authors:  Len Neckers; S Percy Ivy
Journal:  Curr Opin Oncol       Date:  2003-11       Impact factor: 3.645

10.  Heat shock protein expression in canine malignant mammary tumours.

Authors:  Mariarita Romanucci; Alessia Marinelli; Giuseppe Sarli; Leonardo Della Salda
Journal:  BMC Cancer       Date:  2006-06-27       Impact factor: 4.430

View more
  24 in total

1.  Hsp90 inhibitors as senolytic drugs to extend healthy aging.

Authors:  Heike Fuhrmann-Stroissnigg; Laura J Niedernhofer; Paul D Robbins
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

2.  Downregulation of TRAP1 aggravates injury of H9c2 cardiomyocytes in a hyperglycemic state.

Authors:  Xiaodan Zhang; Zhen Zhong; Wangen Li
Journal:  Exp Ther Med       Date:  2019-08-05       Impact factor: 2.447

3.  Gene Copy Number and Post-Transductional Mechanisms Regulate TRAP1 Expression in Human Colorectal Carcinomas.

Authors:  Michele Pietrafesa; Francesca Maddalena; Luciana Possidente; Valentina Condelli; Pietro Zoppoli; Valeria Li Bergolis; Maria Grazia Rodriquenz; Michele Aieta; Giulia Vita; Franca Esposito; Matteo Landriscina
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

4.  Differential expression of HSP90 isoforms and their correlations with clinicopathologic factors in patients with colorectal cancer.

Authors:  Kisu Kim; Hyoun Wook Lee; Eun Hee Lee; Moon-Il Park; Jae Seok Lee; Mee-Seon Kim; Kyungeun Kim; Mee Sook Roh; Min Gyoung Pak; Ji Eun Oh; Kwang Min Kim; Jung Won Lee; Tae Gyu Kim; Hyun-Yeol Nam
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

5.  Heat shock proteins in cancer stem cell maintenance: A potential therapeutic target?

Authors:  Giacomo Lettini; Silvia Lepore; Fabiana Crispo; Lorenza Sisinni; Franca Esposito; Matteo Landriscina
Journal:  Histol Histopathol       Date:  2019-07-19       Impact factor: 2.303

6.  TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.

Authors:  Giacomo Lettini; Lorenza Sisinni; Valentina Condelli; Danilo Swann Matassa; Vittorio Simeon; Francesca Maddalena; Marica Gemei; Elvira Lopes; Giulia Vita; Luigi Del Vecchio; Franca Esposito; Matteo Landriscina
Journal:  Cell Death Differ       Date:  2016-09-23       Impact factor: 15.828

7.  Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.

Authors:  Ru Chen; Sheng Pan; Keith Lai; Lisa A Lai; David A Crispin; Mary P Bronner; Teresa A Brentnall
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery.

Authors:  Zheng Lou; Rong-Gui Meng; Wei Zhang; En-Da Yu; Chuan-Gang Fu
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

Review 9.  Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells.

Authors:  Andrea Rasola; Len Neckers; Didier Picard
Journal:  Trends Cell Biol       Date:  2014-04-11       Impact factor: 20.808

10.  TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.

Authors:  Jackeline Agorreta; Jianting Hu; Dongxia Liu; Domenico Delia; Helen Turley; David J P Ferguson; Francisco Iborra; María J Pajares; Marta Larrayoz; Isabel Zudaire; Ruben Pio; Luis M Montuenga; Adrian L Harris; Kevin Gatter; Francesco Pezzella
Journal:  Mol Cancer Res       Date:  2014-02-24       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.